Dr. Druker's opinion on cancer drugs

[Guest guest]

There is some contention between Pzifer and Forbes magazine about them failing

to produce successful cancer drugs. Dr. Druker has opined on his thoughts about

cancer cures. Anything Dr. Druker says is gospel to a lot of us, as he is a

very humble, thoughtful man who only wants to cure CML in his lifetime. This is

only part of the article, but you can read it all at the website.

Aug. 9 2010

Gleevec Inventor: Why Aren’t There More Cancer Cures?

" Gleevec pioneer Druker of Oregon Health & Science University looks at the

same set of facts and reaches a more optimistic conclusion. “I am seeing the

outline of where we are heading now, but we are still at the beginning,” he

says. “We need to be more intelligent about picking our targets and picking our

drugs and ultimately that will lead to more successes and more rapid successes.”

" Druker, who took a drug that Novartis wasn’t sure what to do with and showed it

had great potential in leukemia, says common cancers are far more complicated

than leukemia. “With CML you are diagnosing it in an early malignant or almost

premalignant phase,” he says. That makes it far easier to treat. CML is driven

by one main gene alteration that is hit by Gleevec. There are far more mutations

in common tumors. " More............

http://blogs.forbes.com/robertlangreth/2010/08/09/gleevec-inventor-why-arent-the\

re-more-cancer-cures/

FYI,

Lottie Duthu